Analysis of the current pharmaceutical environment suggests a clear strategic directive: R&D investment must be directed toward first-in-class therapies and significant therapeutic advances that can justify their prices based on clinical value, not just patent protection
BPC-157 is positioned for wellness support and recovery optimization, not acute medical emergencies
Lets be clear, this is marketing spin, not science, she says
Metabolic changes typically emerge within twenty-five to thirty-two days as therapeutic bacterial strains establish populations and influence hormone secretion
Twice-weekly semaglutide dosing lacks clinical evidence from the trials that established the medication's safety profile
The pivotal 2021 clinical trial of semaglutide revealed that nearly 14% of participants were unable to lose even 5% of their body weight, despite being on the medication for over a year